USD10
ATRA Shares
About Atara BiotherapeuticsAtara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
USD10
ATRA Shares
About Atara BiotherapeuticsAtara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$75.51M
OPEN PRICE
$8.17
LOW (1Y)
$3.92
HIGH (1Y)
$19.15
LOW (24H)
$7.86
HIGH (24H)
$8.67
VOLUME (24H)
$34.5K
64.08%
Price history
Time | Price | Change |
|---|---|---|
Today | $8.17 | |
1 Day | $7.90 | |
1 Week | $8.33 | |
1 Month | $11.50 | |
1 Year | Not enough data | Not enough data |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.